Boothbay Fund Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,761	Closed	-$798K	–	2518
2025 Q4	$798K	Sell	26,761 -34,751	-56%	-$1.13M	0.02%	902
2025 Q3	$2.22M	Sell	61,512 -9,539	-13%	-$314K	0.06%	541
2025 Q2	$2.56M	Buy	71,051 +9,963	+16%	+$371K	0.08%	441
2025 Q1	$2.41M	Sell	61,088 -24,272	-28%	-$817K	0.08%	385
2024 Q4	$2.57M	Buy	+85,360	New	+$2.45M	0.08%	380
2023 Q3	–	Hold	0	–	–	–	2149
2023 Q2	–	Hold	0	–	–	–	2352
2022 Q1	–	Sell	-11,816	Closed	-$225K	–	2610
2021 Q4	$225K	Buy	11,816 +647	+6%	+$16.8K	0.01%	1433
2021 Q3	$372K	Buy	11,169 +401	+4%	+$12.4K	0.01%	1223
2021 Q2	$418K	Buy	10,768 +6,549	+155%	+$257K	0.02%	1097
2021 Q1	$203K	Buy	+4,219	New	+$203K	0.01%	1358
2020 Q4	–	Hold	0	–	–	–	1467
2020 Q1	–	Sell	-52,426	Closed	-$582K	–	1107
2019 Q4	$582K	Buy	+52,426	New	+$399K	0.06%	453
2019 Q3	–	Sell	-59,934	Closed	-$518K	–	944
2019 Q2	$518K	Buy	+59,934	New	+$453K	0.06%	401
2019 Q1	–	Sell	-21,772	Closed	-$89K	–	921
2018 Q4	$89K	Sell	21,772 -18,093	-45%	-$89.9K	0.02%	564
2018 Q3	$223K	Buy	+39,865	New	+$455K	0.03%	625